Cargando…

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment

CUB domain‐containing protein 1 (CDCP1) contributes to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance by regulating EGFR signaling pathways and is a potential target in lung cancer treatment. This study aims to identify a CDCP1 reducer that synergistically improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Sze‐Ching, Yeh, Chun‐Chieh, Zhang, Xun‐Yu, Hsieh, Chih‐Ying, Lo, Chia‐Chien, Kuo, Ting‐Ting, Lin, Ching‐Chan, Chao, Chih‐Hua, Liu, Jing‐Pei, Chang, Ling‐Chu, Wang, Lu‐Hai, Sher, Yuh‐Pyng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399713/ https://www.ncbi.nlm.nih.gov/pubmed/37013960 http://dx.doi.org/10.1002/1878-0261.13429

Ejemplares similares

ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2017)

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015)

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
por: Chou, Cheng-Wei, et al.
Publicado: (2019)

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
por: Cheng, Wei-Chung, et al.
Publicado: (2021)

Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
por: Lin, Ching-Chan, et al.
Publicado: (2020)

Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity
por: Mhone, Thomas Gabriel, et al.
Publicado: (2022)

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
por: Lin, Chen-Yuan, et al.
Publicado: (2017)

Transitions of self-management behaviors and frailty status among community-dwelling older adults: a national longitudinal population-based cohort study
por: To, Thi-Lien, et al.
Publicado: (2022)

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
por: Lin, Yu-Sen, et al.
Publicado: (2021)

An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
por: Chou, Cheng-Wei, et al.
Publicado: (2020)

CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma
por: Liu, Chien-Liang, et al.
Publicado: (2023)

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways
por: He, Yaowu, et al.
Publicado: (2016)

Habitual Physical Activity and Diabetes Control in Young and Older Adults with Type II Diabetes: A Longitudinal Correlational Study
por: Chang, Chia-Hsun, et al.
Publicado: (2021)

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis
por: Karachaliou, Niki, et al.
Publicado: (2018)

Sleep Quality and Associated Factors in Adults with Type 2 Diabetes: A Retrospective Cohort Study
por: Kuo, Ching-Pyng, et al.
Publicado: (2021)

Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer
por: Yang, Lifang, et al.
Publicado: (2015)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
por: Harrington, Brittney S., et al.
Publicado: (2020)

Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth
por: Hsieh, Chia-Chien, et al.
Publicado: (2020)

Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection of Colorectal Cancer
por: Dash, Srinivas, et al.
Publicado: (2022)

Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation
por: Lai, Liang-Chuan, et al.
Publicado: (2011)

Recent advances in conventional and unconventional vesicular secretion pathways in the tumor microenvironment
por: Kuo, I.-Ying, et al.
Publicado: (2022)

CDCP1 promotes compensatory renal growth by integrating Src and Met signaling
por: Kajiwara, Kentaro, et al.
Publicado: (2021)

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
por: Cuda, Tahleesa J., et al.
Publicado: (2021)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

Molnupiravir—A Novel Oral Anti-SARS-CoV-2 Agent
por: Lee, Ching-Chi, et al.
Publicado: (2021)

The efficacy of first-line tyrosine kinase inhibitors combined with co-medications in Asian patients with EGFR mutation non-small cell lung cancer
por: Su, Vincent Yi-Fong, et al.
Publicado: (2020)

Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials
por: Liao, Min-Tsun, et al.
Publicado: (2020)

When to add anti-angiogenesis drugs to EGFR-mutated metastatic non–small cell lung cancer patients: a real-world study from Taiwan
por: Chen, Chieh-Lung, et al.
Publicado: (2022)

Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview
por: Liu, Hao-Li, et al.
Publicado: (2014)

Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma
por: Hong, Xuan, et al.
Publicado: (2023)

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
por: Kryza, Thomas, et al.
Publicado: (2020)

Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
por: Murakami, Yuichi, et al.
Publicado: (2022)

A rapid clinic-based service for an emergency department of a tertiary teaching hospital during a dengue outbreak
por: Shih, Hsin-I., et al.
Publicado: (2021)

Data on a new sensitivity-improved miniaturized label-free electrochemical biosensor
por: Kuo, Yi-Ching, et al.
Publicado: (2018)

Profiling of subcellular EGFR interactome reveals hnRNP A3 modulates nuclear EGFR localization
por: Wang, Tong-Hong, et al.
Publicado: (2020)

EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function
por: Huang, Ching-Wen, et al.
Publicado: (2017)

Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer
por: Lee, Kai-Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8av1juaiub6n6rkm314kus7i6v